Saturday December 15, 2018 00:27

Heathcare Press Release : 20 Nov 2018

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Heathcare—20 Nov 18

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Heathcare—20 Nov 18

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in